GR-46611

GR-46611
Nazivi
	Preferisani IUPAC naziv (E)-3-[3-[2-(dimetilamino)etil]-1H-indol-5-il]-N-[(4-metoksifenil)metil]prop-2-enamid
	Drugi nazivi CHEMBL344127 • 3-(3-(2-dimetilaminoetil)-H-indol-5-il)-N-(4-metoksibenzil)akrilamid • GR 46611 • GR46611 185259-85-2 • GR 46611 • GR46611 • GR 4661 • GR-46611 • SR-01000076206 • GR46611;GR 46611 • Lopac0_000069 • MLS001056583 • SCHEMBL4784832 • CHEBI:93195 • LBVZWEWTNUDWNS-YRNVUSSQSA-N • HMS2233M08 • HMS3260M19 • HMS3411P15
Identifikacija
CAS broj	185259-85-2 ;
3D model (Jmol)	interaktivna slika;
PubChem C ID	6160690;
	SMILES CN(C)CCC1=CNC2=C1C=C(C=C2)C=CC(=O)NCC3=CC=C(C=C3)OC; ; ; ; ; ;
Svojstva
Hemijska formula	C23H27N3O2
Molarna masa	377,49 g·mol−1
	Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
	Reference infokutije

GR-46611 je antagonist 5-HT1A receptora.^[3]

Reference[уреди | уреди извор]

^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
^ Eric P M Prinssen; Francis C Colpaert; Wouter Koek (2002-10-25). „5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy”. Eur J Pharmacol. 453 (2-3): 217—21. doi:10.1016/s0014-2999(02)02430-5.